Molecular Medical Imaging
The Molecular Medical Imaging research group focuses its activity on deepening the molecular bases and developing new areas of research in molecular signaling pathways and the identification of new theranostic targets.
We promote the confluence of basic and clinical researchers, experts in imaging and molecular biology to provide:
- Access to knowledge of the biokinetics and biodistribution of the molecules under study
- The proofs of concept necessary in the research processes
- The identification and quantification of the targets defined by the research groups of our center
In this context, the creation of a translational imaging unit constitutes a basic objective for the development of research aimed at the personalized treatment of patients.
The group is made up of medical specialists in molecular imaging, chemists and pharmacists specializing in tracer synthesis, and biomedical engineers and physicists specializing in image processing and tomography equipment. These are affiliated with different institutions, such as the Vall d'Hebron Research Institute (VHIR), the Vall d'Hebron University Hospital (HUVH) and the Institute of Diagnostic Imaging (IDI).
Publications
The (18)F phantom clinical trials qualification for (18)F-FDG-PET scanning adopted by GELTAMO (Grupo Espanol de Linfomas/Trasplante Autologo de Medula Osea).
PMID: 33485832
Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular
Year: 2021
Reference: Rev Esp Med Nucl Imagen Mol. 2021 May-Jun;40(3):149-154. doi: 10.1016/j.remn.2020.06.003. Epub 2021 Jan 21.
Impact factor: 1.359
Publication type: Paper in national publication
Authors: Bergesio, Fabrizio, De Maggi, Adriano, Coronado, Monica, Pardal, Emilia, Plaza, Rafael, Hernandez, Ana Cristina, Sarandeses, Maria Del Pilar, Cortes, Montserrat, Setoain, Xavier, Simo, Marc et al.
DOI: 10.1016/j.remn.2020.06.003
Single pulmonary nodule with reverse halo sign in COVID-19 infection: Incidental finding on FDG PET/CT scan.
PMID: 33246573
Journal: MEDICINA CLINICA
Year: 2021
Reference: Med Clin (Barc). 2021 Jan 22;156(2):102. doi: 10.1016/j.medcli.2020.10.011. Epub 2020 Nov 6.
Impact factor: 1.725
Publication type: Letter or abstract
Authors: Varona Porres, Diego, Simo, Marc, Sanchez, Ana Lucia, Cabanzo, Laura, Andreu, Jordi et al.
DOI: 10.1016/j.medcli.2020.10.011
Evaluation of the modified CT severity index (MCTSI) and CT severity index (CTSI) in predicting severity and clinical outcomes in acute pancreatitis.
PMID: 33184988
Journal: Journal of Digestive Diseases
Year: 2021
Reference: J Dig Dis. 2021 Jan;22(1):41-48. doi: 10.1111/1751-2980.12961. Epub 2020 Dec 22.
Impact factor: 2.325
Publication type: Paper in international publication
Authors: Vidal, Laura, Roson, Nuria, Mast, Richard, Armario, David, Merino, Xavier, Dopazo, Cristina, Blanco, Laia, Caralt, Mireia, Gomez, Concepcion, Balsells, Joaquim et al.
DOI: 10.1111/1751-2980.12961
Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments.
PMID: 33002230
Journal: JOURNAL OF SURGICAL ONCOLOGY
Year: 2021
Reference: J Surg Oncol. 2021 Jan;123(1):71-79. doi: 10.1002/jso.26236. Epub 2020 Oct 1.
Impact factor: 3.454
Publication type: Paper in international publication
Authors: Esgueva, Antonio, Siso, Christian, Espinosa-Bravo, Martin, Sobrido, Carolina, Miranda, Ignacio, Salazar, Juan P, Rubio, Isabel T et al.
DOI: 10.1002/jso.26236
News
The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.
The device, called Winco USG, is a simulation platform for holistic and integrated training of professionals performing this type of procedure.
Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.